FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

4 results

dalvance
(Dalbavancin)
Allergan, Inc.
Usage: DALVANCE® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatrics caused by specific Gram-positive bacteria, including methicillin-susceptible and methicillin-resistant Staphylococcus aureus, and various Streptococcus and Enterococcus species. Usage should target infections caused by susceptible strains to minimize resistance.
kimyrsa
(oritavancin diphosphate)
Melinta Therapeutics, LLC
Usage: KIMYRSA® is indicated for treating adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by specific Gram-positive bacteria, including methicillin-susceptible and resistant Staphylococcus aureus, various Streptococcus species, and vancomycin-susceptible Enterococcus faecalis. Use only for proven or suspected susceptible infections.
orbactiv
(oritavancin)
Melinta Therapeutics, LLC
Usage: ORBACTIV® (oritavancin) is indicated for treating adult patients with acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-susceptible Enterococcus faecalis. It should be used to prevent drug-resistant bacteria and tailored based on culture results when available.
vibativ
(telavancin hydrochloride)
Cumberland Pharmaceuticals Inc.
Usage: VIBATIV is indicated for adults with complicated skin and skin structure infections (cSSSI) and hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-positive organisms, including methicillin-susceptible and -resistant Staphylococcus aureus. It may be used as empiric therapy in certain cases.

Lipoglycopeptide Antibacterial class drugs

dalvance

kimyrsa

orbactiv

vibativ